Whole-body PET/CT predicts response to HER2-targeted therapy

Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients

medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Sweden , Ali Alhuseinalkhudhur , Pathology At Uppsala University In , Journal Of Nuclear Medicine , Department Of Immunology , Nuclear Medicine , Uppsala University , Human Epidermal Growth Factor Receptor , Early Metabolic Response , Metastatic Breast Cancer ,